Bromisoval or bromvalerylurea

This classification denotes a sedative and hypnotic with the molecular formula C6H11BrN2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 469GW8R486, chemically known as urea, (2-bromo-3-methylbutyryl)- but generally known as bromisoval, which bears US NIH Compound Identifier 2447. European Medicines Agency schedules Bromisoval in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05916MIG. The term BROMISOVAL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, No. 10 1976, List 16). World Health Organization schedules bromisoval in its Anatomical Therapeutic Chemical (ATC) Classification. BROMISOVAL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Bromisoval or bromvalerylurea bears US NLM identifiers UMLS ID C0006226 and NCI Concept Code C76935. SMILES: BRC(C(C)C)C(=O)NC(=O)N.